Multiple symmetrical lipomatosis
Multiple Symmetrical Lipomatosis | |
---|---|
Synonyms | Madelung's disease, Launois-Bensaude syndrome |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Symmetrical fatty deposits, mainly in the neck, shoulders, and upper arms |
Complications | Respiratory issues, sleep apnea, neuropathy |
Onset | Typically in adulthood |
Duration | Chronic |
Types | N/A |
Causes | Unknown, possibly genetic and environmental factors |
Risks | Alcoholism, metabolic disorders |
Diagnosis | Clinical examination, imaging studies |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Surgical removal, lifestyle changes |
Medication | N/A |
Prognosis | Variable, depends on severity and treatment |
Frequency | Rare |
Deaths | N/A |
Multiple Symmetrical Lipomatosis (MSL), also known as Madelung's disease or Launois-Bensaude syndrome, is a rare disorder characterized by the growth of unencapsulated, symmetrical fatty deposits. These deposits are primarily located in the neck, shoulders, and upper arms.
Epidemiology[edit | edit source]
MSL is a rare condition with a higher prevalence in Mediterranean populations. It predominantly affects middle-aged men, with a male-to-female ratio of approximately 15:1. The exact incidence is unknown, but it is considered a rare disease.
Etiology[edit | edit source]
The exact cause of MSL is not well understood. However, it is believed to involve a combination of genetic and environmental factors. There is a strong association with alcoholism, and some studies suggest a link with mitochondrial DNA mutations. Other potential risk factors include metabolic disorders such as dyslipidemia and diabetes mellitus.
Pathophysiology[edit | edit source]
The pathophysiology of MSL involves the abnormal proliferation of adipose tissue. Unlike typical lipomas, the fatty deposits in MSL are not encapsulated and are diffusely distributed. The condition is thought to result from a defect in the regulation of lipid metabolism, possibly involving mitochondrial dysfunction.
Clinical Presentation[edit | edit source]
Patients with MSL typically present with symmetrical, non-tender fatty masses. These masses are most commonly found in the cervical region, giving a characteristic "horse collar" appearance. Other common sites include the upper back, arms, and thighs.
Symptoms[edit | edit source]
- Symmetrical fatty deposits - Limited range of motion - Cosmetic concerns - Possible respiratory issues due to compression of the airway - Sleep apnea - Peripheral neuropathy
Diagnosis[edit | edit source]
The diagnosis of MSL is primarily clinical, based on the characteristic distribution of fatty deposits. Imaging studies such as computed tomography (CT) or magnetic resonance imaging (MRI) can be used to assess the extent of the disease and to differentiate MSL from other conditions such as liposarcoma.
Differential Diagnosis[edit | edit source]
- Lipoma - Liposarcoma - Dercum's disease - Familial multiple lipomatosis
Management[edit | edit source]
There is no definitive cure for MSL, and management focuses on symptomatic relief and cosmetic improvement.
Surgical Treatment[edit | edit source]
- Liposuction: Often used to remove excess fat deposits. - Surgical excision: May be necessary for larger masses or when liposuction is insufficient.
Non-Surgical Treatment[edit | edit source]
- Lifestyle modifications: Reducing alcohol intake and managing metabolic disorders. - Physical therapy: To improve mobility and function.
Prognosis[edit | edit source]
The prognosis of MSL varies. While the condition is benign, it can lead to significant cosmetic and functional impairment. The risk of recurrence after surgical treatment is high, and ongoing management may be necessary.
Complications[edit | edit source]
- Respiratory distress - Obstructive sleep apnea - Peripheral neuropathy
See Also[edit | edit source]
- Lipomatosis - Adipose tissue - Metabolic syndrome
External Links[edit | edit source]
- [Link to a relevant medical resource]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD